Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inactivated EV71 Vaccine Immunogenicity and Safety in Healthy Children
NCT05913024Phase 2Completed
- Sponsor
- Zhifei Green Bamboo
- Start
- Oct 2021
- Primary completion
- Oct 2022
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of enterovirus 71 vaccine (vero cell), inactivated in HIV-associated central nervous system involvement (HAND), sponsored by Zhifei Green Bamboo. Started Oct 2021; status: completed.
02
Drugs
enterovirus 71 vaccine (vero cell), inactivated
03
Conditions
HIV-associated central nervous system involvement (HAND)
Beyond the preview
Go deeper on NCT05913024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05913024.